Professional
Added to YB: 2024-05-09
Pitch date: 2024-05-05
PCHM [bullish]
PharmChem, Inc.
+46.27%
current return
Author Info
Cedar Creek Partners provides deep-dive research on undervalued companies. Follow on Twitter/X.
Company Info
PharmChem, Inc. provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana.
Market Cap
$15.2M
Pitch Price
$2.56
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
-9.37
EV/Sales
N/A
Sector
Health Care Equipment and Supplies
Category
special_situation
Cedar Creek Partners Portfolio Holding: PharmChem, Inc.
PCHM: Fund's 33% stake, Q1 bid $2.71 vs $2.56 EOY '23. Makes sweat patches for drug testing. Cut private employer & direct-to-consumer spend. CEO out, director named interim. '23: 12% diluted shares repurchased, $0.20 div, $0.17 EPS. Q1 $0.034 EPS after one-time costs, $0.05 proforma. CEO change eliminates option expense.
Read full article (1 min)